Shattuck Labs, Inc.
General ticker "STTK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $64.3M (TTM average)
Shattuck Labs, Inc. follows the US Stock Market performance with the rate: 43.9%.
Estimated limits based on current volatility of 5.2%: low 2.48$, high 2.75$
Factors to consider:
- Total employees count: 105 as of 2022
- Top business risk factors: Early clinical stage losses and no products, Public health crises, Labor/talent shortage/retention, Operational and conduct risks, Regulatory and compliance
- Current price 39.4% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.57$, 2.13$]
- 2025-12-31 to 2026-12-31 estimated range: [0.46$, 1.59$]
Financial Metrics affecting the STTK estimates:
- Positive: with PPE of -0.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Shareholder equity ratio, % of 87.45 > 63.39
- Negative: Operating cash flow per share per price, % of -105.09 <= 0.33
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term STTK quotes
Long-term STTK plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.65MM | $1.66MM | $5.72MM |
| Operating Expenses | $103.98MM | $93.61MM | $86.29MM |
| Operating Income | $-103.33MM | $-91.96MM | $-80.57MM |
| Non-Operating Income | $1.38MM | $4.66MM | $5.16MM |
| R&D Expense | $82.90MM | $74.31MM | $67.21MM |
| Income(Loss) | $-101.94MM | $-87.30MM | $-75.41MM |
| Profit(Loss)* | $-101.94MM | $-87.30MM | $-75.41MM |
| Stockholders Equity | $176.16MM | $144.71MM | $79.63MM |
| Assets | $205.32MM | $159.56MM | $91.05MM |
| Operating Cash Flow | $-94.50MM | $-81.23MM | $-60.52MM |
| Capital expenditure | $11.61MM | $0.41MM | $0.06MM |
| Investing Cash Flow | $49.44MM | $110.86MM | $-8.51MM |
| Financing Cash Flow | $0.17MM | $48.62MM | $0.79MM |
| Earnings Per Share** | $-2.41 | $-2.05 | $-1.49 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.